Sustanon 350 anti-inflammatory effect, and stimulates the regeneration of the skin reduces the likelihood of suppuration, increasing the intracellular synthesis of nucleic acids and proteins and activating fibroblastic reaction in the dermis. The ointment also has a photoprotective effect. Due to emulsion based Stizamet easily penetrates the skin. When applied to the skin metiluratsila maximum concentration in blood is reached after 2 hours, half-life is 5.1 hours.
Indications for use
Inflammatory skin diseases (eczema, atopic dermatitis, dermatitis), poorly healing wounds, burns (reparative stage) erosion and skin ulcers (including after radiotherapy), anus cracked skin and mammary glands. It is also used as a photoprotective agent in photodermatosis.
Acute and chronic forms of leukemia and other malignant diseases of the system hematopoiesis.
Be wary used for skin sustanon 350 diseases, accompanied by the formation of excess tissue growths:. Vegetating pemphigus, vegetating pyoderma, verrucous form of lichen planus, verrucous epidermodysplasia etc. The drug should also be used with caution in acute inflammatory diseases of the skin and in the period of exacerbation of chronic, on large areas of skin – in violation of cholesterol metabolism and severe liver disease.
Dosage and administration
Ointment applied thinly to the affected areas of skin 2 times a day, with erosions, ulcers and wounds – after pre-treatment with antiseptics. Single dose rate of the treated area of the skin surface is from 1 to 10 g of ointment. Duration of treatment – until they are healed. In chronic course length – up to 2 months. Heading dose can be 60-80 grams or more.
The interaction with other drugs
can assign dermotropic concurrently sustanon 350 with other means, including glucocorticoids.